ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Reprogramming CD22 CAR-T cells in vivo using CD8-targeted mRNA-LNPs to treat hematological malignancies.

Viktor T Lemgart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.